Comparison of Robot Assisted Gait Training and Body Weight Supported Treadmill Training Using Gait Analysis and SEMG Measurements

Pamukkale University

Status: Completed

Conditions: Stroke, Ischemic

Treatments: Device: RehaWalk; Other: Conventional; Device: RoboGait

Study type: Interventional

Funder types: Other

Identifiers

NCT06715098

PamukkaleU.ftr-FArdıç-001

Details and patient eligibility

About

The aim of our randomized controlled clinical trial was to analyze the effects of robotic-assisted gait training and body-weight-supported treadmill training on gait analysis parameters and lower extremity agonist and antagonist muscle activities in stroke patients and to compare their effectiveness in improving locomotor function. The main questions that the researchers aimed to answer are: What are the effects of robotic-assisted gait training and body-weight-supported treadmill training on gait analysis parameters in stroke patients? What are the effects of robotic-assisted gait training and body-weight-supported treadmill training on lower extremity agonist and antagonist muscle activities in stroke patients? What is the effectiveness of robotic-assisted gait training and body-weight-supported treadmill training in improving locomotor function in stroke patients? The patients included in the study were randomly divided into three groups: The first group received robotic-assisted gait training with RoboGait, the second group received body-weight-supported gait training on a treadmill with RehaWalk, and the third group received conventional walking training.

Enrollment: 45 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 and above
• Chronic stage stroke (6 months - 2 years)
• First stroke
• Spasticity of Ashworth stage 2 or lower
• Ability to follow commands
• Ability to walk unsupported for more than 10 meters
• No treatment received in the last month

Exclusion criteria

• Severe osteoporosis
• Unstable fracture
• Excessive spasticity (Ashworth stage 3 and above)
• Cognitive impairment

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

45 participants in 3 patient groups

RoboGait group

Experimental group

Description:

Robotic walking training 3 days a week, 30 minutes a day for 4 weeks

Treatment:

Device: RoboGait

RehaWalk group

Experimental group

Description:

Walking training on treadmill with body weight support for 30 minutes a day, 3 days a week for 4 weeks

Treatment:

Device: RehaWalk

Conventional Group

Active Comparator group

Description:

Conventional walking training for 30 minutes a day, 3 days a week for 4 weeks

Treatment:

Other: Conventional